Natera, Inc. Profile Avatar - Palmy Investing

Natera, Inc.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as tw…
Medical - Diagnostics & Research
US, San Carlos [HQ]
Major Shareholders · Proxy Ben. Owners

Shareholders

Breakdown
Beneficial Owners Beta
Soon Available - Stay Tuned
End of NTRA's Analysis
CIK: 1604821 CUSIP: 632307104 ISIN: US6323071042 LEI: - UEI: -
Secondary Listings
NTRA has no secondary listings inside our databases.